Hainan Huluwa Pharmaceutical Group Co Ltd (605199) - Total Liabilities

Latest as of September 2025: CN¥2.06 Billion CNY ≈ $302.05 Million USD

Based on the latest financial reports, Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has total liabilities worth CN¥2.06 Billion CNY (≈ $302.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Hainan Huluwa Pharmaceutical Group Co Lt to assess how effectively this company generates cash.

Hainan Huluwa Pharmaceutical Group Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Hainan Huluwa Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 605199 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Hainan Huluwa Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hainan Huluwa Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
MK Electron Co. Ltd KQ:033160	Korea	₩1.48 Trillion
Taiwan Steel Union Co Ltd TW:6581	Taiwan	NT$818.73 Million
Companhia Brasileira de Distribuição MX:CBDN	Mexico	MX$15.64 Billion
Commercial Bancgroup, Inc. Common Stock NASDAQ:CBK	USA	$2.01 Billion
Samhi Hotels Limited NSE:SAMHI	India	Rs20.08 Billion
Natures Sunshine Products Inc NASDAQ:NATR	USA	$98.10 Million
Panoro Energy ASA F:1PZ	Germany	€444.78 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Hainan Huluwa Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hainan Huluwa Pharmaceutical Group Co Lt (605199) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.82	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.99	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hainan Huluwa Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2024)

The table below shows the annual total liabilities of Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.22 Billion ≈ $325.04 Million	+16.84%
2023-12-31	CN¥1.90 Billion ≈ $278.20 Million	+46.61%
2022-12-31	CN¥1.30 Billion ≈ $189.76 Million	+56.16%
2021-12-31	CN¥830.41 Million ≈ $121.51 Million	+37.33%
2020-12-31	CN¥604.68 Million ≈ $88.48 Million	+36.60%
2019-12-31	CN¥442.67 Million ≈ $64.78 Million	-9.17%
2018-12-31	CN¥487.37 Million ≈ $71.32 Million	+6.92%
2017-12-31	CN¥455.83 Million ≈ $66.70 Million	+11.93%
2016-12-31	CN¥407.26 Million ≈ $59.59 Million	--

About Hainan Huluwa Pharmaceutical Group Co Ltd

SHG:605199 China Drug Manufacturers - Specialty & Generic

Market Cap

$383.49 Million

CN¥2.62 Billion CNY

Market Cap Rank

#13904 Global

#4368 in China

Share Price

CN¥6.55

Change (1 day)

-3.53%

52-Week Range

CN¥6.12 - CN¥10.65

All Time High

CN¥48.21